Effects of a combination of detomidine and butorphanol on respiratory function in horses with or without chronic obstructive pulmonary disease.

The research article explores the impact of combining detomidine and butorphanol on the respiratory function of horses, looking at healthy horses as well as horses suffering from chronic obstructive pulmonary disease.

Study Methods:

• The study involved 10 horses split into two groups: those with chronic obstructive pulmonary disease (COPD) and healthy horses.
• Pulmonary function testing and arterial blood gas analyses were carried out before and after administering detomidine and butorphanol, dosed at 10 micrograms/kg and 20 micrograms/kg, respectively.
• Respiratory flow rates were gathered from a pneumotachograph attached to a face mask, and the pressure in the oesophagus was measured using a catheter placed in the lower third of the oesophagus.
• Respiratory rate, tidal volume (VT), minute ventilation (VE), maximum transpulmonary pressure change, pulmonary resistance, and dynamic compliance were calculated using a pulmonary function computer.
• Arterial blood was drawn from the transverse facial artery for blood gas partial pressures measurement using an automated blood gas analyzer.

Findings:

• The combination of detomidine and butorphanol caused significant changes in respiratory rate, tidal volume (VT), minute ventilation (VE), PaO2, and PaCO2 over time.
• Differences in changes in VT, VE, and maximum transpulmonary pressure change over time were notable between the two groups.

Conclusions:

• The combination of detomidine and butorphanol does have an impact on the respiratory function of horses, and these effects are influenced by existing respiratory dysfunction.
• The changes in respiratory function after administering the combination of detomidine and butorphanol are not necessarily more severe in horses with pre-existing respiratory dysfunction.